{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:21:33Z","timestamp":1778620893231,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560171"],"award-info":[{"award-number":["81560171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20155338"],"award-info":[{"award-number":["20155338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.intimp.2019.106011","type":"journal-article","created":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T07:57:52Z","timestamp":1574582272000},"page":"106011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effects of lentivirus-mediated CCR3 RNA interference on the function of mast cells of allergic rhinitis in mice"],"prefix":"10.1016","volume":"78","author":[{"given":"Shuhong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haisen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaokun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.106011_b0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.02.011","article-title":"Emerging concepts: mast cell involvement in allergic diseases","volume":"174","author":"Modena","year":"2016","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"key":"10.1016\/j.intimp.2019.106011_b0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2015.04.046","article-title":"Mast cells in airway diseases and interstitial lung disease","volume":"778","author":"Cruse","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106011_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MCP.0000000000000228","article-title":"Revisiting the role of the mast cell in asthma","volume":"22","author":"Andersson","year":"2016","journal-title":"Curr. Opin. Pulmonary Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.pharmthera.2014.01.004","article-title":"Targeting mast cells in inflammatory diseases","volume":"142","author":"Reber","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5114\/pjp.2017.71526","article-title":"Mast cells as the strength of the inflammatory process","volume":"68","author":"Pastwinska","year":"2017","journal-title":"Polish J. Pathol.: Off. J. Polish Soc. Pathol."},{"key":"10.1016\/j.intimp.2019.106011_b0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pharmthera.2016.10.010","article-title":"Mast cell and eosinophil surface receptors as targets for anti-allergic therapy","volume":"170","author":"Gangwar","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2019.106011_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.18176\/jiaci.0327","article-title":"Mast cells as key players in allergy and inflammation","volume":"28","author":"Gonzalez-de-Olano","year":"2018","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"issue":"2 Suppl 2","key":"10.1016\/j.intimp.2019.106011_b0040","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106011_b0045","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/cea.12780","article-title":"Pathogenesis of rhinitis, Clinical and experimental allergy","volume":"46","author":"Eifan","year":"2016","journal-title":"J. Br. Soc. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0050","first-page":"202","article-title":"[Recent advances in allergic rhinitis]","volume":"29","author":"Liang","year":"2015","journal-title":"Lin chuang er bi yan hou tou jing wai ke za zhi = J. Clin. Otorhinolaryngol., Head, Neck Surgery"},{"issue":"5","key":"10.1016\/j.intimp.2019.106011_b0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMcp1412282","article-title":"Clinical practice. Allergic rhinitis","volume":"372","author":"Wheatley","year":"2015","journal-title":"New England J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.106011_b0060","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jaci.2017.03.050","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision","volume":"140","author":"Brozek","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106011_b0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14728214.2016.1139082","article-title":"Emerging drugs for the treatment of perennial allergic rhinitis","volume":"21","author":"Licari","year":"2016","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2019.106011_b0070","first-page":"S35","article-title":"Pharmacotherapy for allergic rhinitis","volume":"4","author":"Platt","year":"2014","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2019.106011_b0075","first-page":"S51","article-title":"Subcutaneous immunotherapy","volume":"4","author":"Roche","year":"2014","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4168\/aair.2016.8.3.191","article-title":"Allergen immunotherapy: past, present, and future","volume":"8","author":"Jutel","year":"2016","journal-title":"Allergy Asthma Immunol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2019.106011_b0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.gene.2013.12.019","article-title":"Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies","volume":"538","author":"Deng","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.intimp.2019.106011_b0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jconrel.2014.04.044","article-title":"Development of RNAi technology for targeted therapy\u2013a track of siRNA based agents to RNAi therapeutics","volume":"193","author":"Zhou","year":"2014","journal-title":"J. Controlled Release: Off. J. Controlled Release Soc."},{"key":"10.1016\/j.intimp.2019.106011_b0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12931-014-0132-z","article-title":"Small interfering RNA against CD86 during allergen challenge blocks experimental allergic asthma","volume":"15","author":"Asai-Tajiri","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2019.106011_b0100","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1038\/srep13127","article-title":"Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K\/AKT signaling pathway","volume":"5(1)","author":"Lin","year":"2015","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2019.106011_b0105","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1517\/14712598.2014.935334","article-title":"An update on RNA interference-mediated gene silencing in cancer therapy","volume":"14","author":"Ren","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.intimp.2019.106011_b0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2014.07.056","article-title":"Current issues of RNAi therapeutics delivery and development","volume":"195","author":"Haussecker","year":"2014","journal-title":"J. Controlled Release: Off. J. Controlled Release Soc."},{"issue":"1","key":"10.1016\/j.intimp.2019.106011_b0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3892\/etm.2016.3965","article-title":"Effects of chemokine receptor 3 gene silencing by RNA interference on eosinophils","volume":"13","author":"Liu","year":"2017","journal-title":"Exp. Therap. Med."},{"issue":"8","key":"10.1016\/j.intimp.2019.106011_b0120","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/bjophthalmol-2011-301399","article-title":"The murine CCR3 receptor regulates both eosinophilia and hyperresponsiveness in IgE-mediated allergic conjunctivitis","volume":"96","author":"Fukuda","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106011_b0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2567.2009.03151.x","article-title":"The function of CCR3 on mouse bone marrow-derived mast cells in vitro","volume":"129","author":"Collington","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2019.106011_b0130","doi-asserted-by":"crossref","unstructured":"D. Miyazaki, T. Nakamura, M.C. Kuo, N. Komatsu, K. Yakura, T. Tominaga, Y. Inoue, H. Higashi, M. Murata, S. Takeda, Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1\/CCR3 blockade, Int. Immunol. 21(2) (2009) 187\u2013201.","DOI":"10.1093\/intimm\/dxn137"},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1073\/pnas.261462598","article-title":"The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness","volume":"99","author":"Humbles","year":"2002","journal-title":"Proc. Nat. Acad. Sci. United States of America"},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0140","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1159\/000478645","article-title":"MicroRNA-133b Ameliorates Allergic Inflammation and Symptom in Murine Model of Allergic Rhinitis by Targeting Nlrp3","volume":"42","author":"Xiao","year":"2017","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol., Biochem., Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106011_b0145","first-page":"123","volume":"273","author":"Ku","year":"2016","journal-title":"Head Neck Surg."},{"issue":"2","key":"10.1016\/j.intimp.2019.106011_b0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2006.07.007","article-title":"Knocking down disease with siRNAs","volume":"126","author":"Dykxhoorn","year":"2006","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.intimp.2019.106011_b0155","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.addr.2009.04.004","article-title":"siRNA vs. shRNA: similarities and differences","volume":"61","author":"Rao","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2019.106011_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091249","article-title":"Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside","volume":"21","author":"Qiu","year":"2016","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"10.1016\/j.intimp.2019.106011_b0165","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/156652308785160692","article-title":"RNA interference: new therapeutics in allergic diseases","volume":"8","author":"Lee","year":"2008","journal-title":"Curr. Gene Ther."},{"issue":"4","key":"10.1016\/j.intimp.2019.106011_b0170","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/156652409788167041","article-title":"Targeting allergic airway diseases by siRNA: an option for the future?","volume":"9","author":"Meinicke","year":"2009","journal-title":"Curr. Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.106011_b0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4168\/aair.2017.9.4.360","article-title":"CCR3 Monoclonal Antibody Inhibits Eosinophilic Inflammation and Mucosal Injury in a Mouse Model of Eosinophilic Gastroenteritis","volume":"9","author":"Song","year":"2017","journal-title":"Allergy, Asthma Immunol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jep.2012.05.039","article-title":"Antiallergic effect of KOB03, a polyherbal medicine, on mast cell-mediated allergic responses in ovalbumin-induced allergic rhinitis mouse and human mast cells","volume":"142","author":"Won Jung","year":"2012","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030504","article-title":"The Anti-Allergic Rhinitis Effect of Traditional Chinese Medicine of Shenqi by Regulating Mast Cell Degranulation and Th1\/Th2 Cytokine Balance","volume":"22","author":"Shao","year":"2017","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.intimp.2019.106011_b0190","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaci.2017.08.039","article-title":"Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis","volume":"141","author":"Steelant","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2019.106011_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.intimp.2017.08.029","article-title":"Skullcapflavone II attenuates ovalbumin-induced allergic rhinitis through the blocking of Th2 cytokine production and mast cell histamine release","volume":"52","author":"Bui","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.106011_b0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2015.04.045","article-title":"Mast cell proteases as pharmacological targets","volume":"778","author":"Caughey","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2019.106011_b0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.aller.2012.04.004","article-title":"Tryptase: genetic and functional considerations","volume":"40","author":"Hernandez-Hernandez","year":"2012","journal-title":"Allergol. Immunopathol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919321459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919321459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:53:53Z","timestamp":1778619233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919321459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":41,"alternative-id":["S1567576919321459"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of lentivirus-mediated CCR3 RNA interference on the function of mast cells of allergic rhinitis in mice","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106011"}}